trending Market Intelligence /marketintelligence/en/news-insights/trending/x12excv9azr6osdau_xp4g2 content esgSubNav
In This List

Ampio Pharmaceuticals chief scientific officer to retire

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Ampio Pharmaceuticals chief scientific officer to retire

Ampio Pharmaceuticals Inc. said David Bar-Or will retire as chief scientific officer, effective Sept. 30.

Bar-Or will remain on the Englewood, Colo.-based biopharmaceutical company's board.

He said he plans to do some projects at the Trauma Research Center where he serves as research director for eight medical institutions.